Why do life sciences deals fail? Insights from industry dealmakers
Dealmaking is a key driver of innovation and growth for life sciences companies. Regulation, complexity, scientific discovery and uncertainty are hallmarks of the sector, but can lead to higher-than-average attrition rates for deals.
This report, based on interviews with life sciences dealmaking veterans, looks at key risk factors for buyers and sellers in life sciences deals - and how to avoid them to increase the probability of deal success.
Please complete the form opposite to download the report.
%20front%20cover%20reduced.jpg "Image of pills spilling from open bottle")
